世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の臨床CRO市場の洞察、2029年までの予測


Global Clinical CRO Market Insights, Forecast to 2029

医薬品開発業務受託機関（CRO）とは、製薬、バイオテクノロジー、医療機器業界に対し、研究サービスのアウトソーシングという形でサポートを提供する企業である。CROは、バイオ医薬品開発、生物学的アッセイ開発... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2023年8月2日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

医薬品開発業務受託機関（CRO）とは、製薬、バイオテクノロジー、医療機器業界に対し、研究サービスのアウトソーシングという形でサポートを提供する企業である。CROは、バイオ医薬品開発、生物学的アッセイ開発、商業化、前臨床研究、臨床研究、臨床試験管理、ファーマコビジランスなどのサービスを提供する。

CROは、新薬やニッチ市場の医薬品を開発する企業のコスト削減を目的としている。CROの目的は、医薬品市場への参入を簡素化し、開発を簡素化することである。CROはまた、政府機関だけでなく、財団、研究機関、大学も支援している。

市場分析と洞察世界の臨床CRO市場
世界の臨床CRO市場は、2023年の100万米ドルから2029年には100万米ドルに成長し、予測期間中の年間平均成長率（CAGR）は％と予測されています。
米国とカナダの臨床CRO市場は、2023年の100万米ドルから2029年には100万米ドルに達すると予測され、2023年から2029年の予測期間中に年平均成長率（CAGR）％で増加すると予測される。
臨床 CRO の中国市場は、2023 年の 100 万ドルから 2029 年には 100 万ドルに達すると推計され、2023 年から 2029 年までの予測期間中の年平均成長率は % である。
臨床CROのヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中の年平均成長率は%である。
臨床CROの世界の主要企業は、IQVIA、Covance、Syneos Health、Pharmaceutical Product Development（PPD）、PAREXEL International、MedPace、Clintec、PRA Health Sciences、KCRなどである。

レポートの内容
本レポートでは、臨床CROの世界市場規模について概観します。2018年～2022年の過去の市場収益データ、2023年の推定値、2029年までのCAGR予測による世界市場動向の分析。
臨床CROの主要生産者を調査し、主要地域と国の収益も掲載しています。臨床CROの今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国に焦点を当てたハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他諸国の国別データと市場価値分析。

本レポートは、2018年から2023年までのデータで、主要企業の臨床CRO収益、市場シェア、業界ランキングに焦点を当てています。世界の臨床CRO市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争環境を理解し、より多くの洞察を得て、より良い方法で事業や市場戦略を位置づけるのに役立ちます。
本レポートでは、2018年から2029年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。臨床CROの収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
IQVIA、Covance、Syneos Health、Pharmaceutical Product Development（PPD）、PAREXEL International、MedPace、Clintec、PRA Health Sciences、KCRなど、世界の主要企業の詳細な企業プロフィール。

会社別
IQVIA
コーヴァンス
シネオス・ヘルス
医薬品開発（PPD）
パレクセル・インターナショナル
メドペース
クリンテック
PRAヘルスサイエンス
KCR
アイコン
クインタイルズ・トランスナショナル
パレクセル
チャールズ・リバー・ラボラトリーズ（CRL）
メディデータ・ソリューションズ
ファーマロン
GVKバイオサイエンシズ・プライベート・リミテッド
無錫ファルマテック（ケイマン）
杭州タイガーメッドコンサルティング
アシムケム
ファーマブロックサイエンシズ
ジョインラボラトリーズ
クラウンバイオサイエンス
メディシロン
江門量子ハイテクバイオロジカル
広州博滋医療生物技術有限公司
タイプ別セグメント
ディスカバリー
CMC
前臨床
臨床研究
ラボサービス
アプリケーション別セグメント
製薬・バイオ製薬企業
医療機器企業
学術機関
地域別
北米
米国
カナダ
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東、アフリカ、中南米
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章： レポートのスコープ、各市場セグメント（製品タイプ、用途など）の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性についてハイレベルな見解を示しています。
第2章：臨床CROの世界および地域レベルでの収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、キャパシティなどを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析についても紹介しています。
第3章：臨床CRO企業の競争環境、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章: 各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展可能性を網羅し、読者が各市場セグメントにおけるブルーオーシャン市場を見出すのに役立つ。
第5章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第6章：北米：タイプ別、用途別、国別、セグメント別の収益。
第7章：ヨーロッパ：タイプ別、用途別、国別、セグメント別収益。
第8章：中国：タイプ別、用途別、セグメント別収益。
第9章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別収益。
第10章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別収益。
第11章：主要企業のプロファイルを提供し、製品の説明や仕様、臨床CROの収益、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章：アナリストの視点/結論


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical CRO Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Discovery
1.2.3 CMC
1.2.4 Preclinical
1.2.5 Clinical Research
1.2.6 Laboratory Services
1.3 Market by Application
1.3.1 Global Clinical CRO Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Academic Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical CRO Market Perspective (2018-2029)
2.2 Global Clinical CRO Growth Trends by Region
2.2.1 Clinical CRO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical CRO Historic Market Size by Region (2018-2023)
2.2.3 Clinical CRO Forecasted Market Size by Region (2024-2029)
2.3 Clinical CRO Market Dynamics
2.3.1 Clinical CRO Industry Trends
2.3.2 Clinical CRO Market Drivers
2.3.3 Clinical CRO Market Challenges
2.3.4 Clinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Clinical CRO by Players
3.1.1 Global Clinical CRO Revenue by Players (2018-2023)
3.1.2 Global Clinical CRO Revenue Market Share by Players (2018-2023)
3.2 Global Clinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Clinical CRO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Clinical CRO Market Concentration Ratio
3.4.1 Global Clinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical CRO Revenue in 2022
3.5 Global Key Players of Clinical CRO Head office and Area Served
3.6 Global Key Players of Clinical CRO, Product and Application
3.7 Global Key Players of Clinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical CRO Breakdown Data by Type
4.1 Global Clinical CRO Historic Market Size by Type (2018-2023)
4.2 Global Clinical CRO Forecasted Market Size by Type (2024-2029)
5 Clinical CRO Breakdown Data by Application
5.1 Global Clinical CRO Historic Market Size by Application (2018-2023)
5.2 Global Clinical CRO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical CRO Market Size (2018-2029)
6.2 North America Clinical CRO Market Size by Type
6.2.1 North America Clinical CRO Market Size by Type (2018-2023)
6.2.2 North America Clinical CRO Market Size by Type (2024-2029)
6.2.3 North America Clinical CRO Market Share by Type (2018-2029)
6.3 North America Clinical CRO Market Size by Application
6.3.1 North America Clinical CRO Market Size by Application (2018-2023)
6.3.2 North America Clinical CRO Market Size by Application (2024-2029)
6.3.3 North America Clinical CRO Market Share by Application (2018-2029)
6.4 North America Clinical CRO Market Size by Country
6.4.1 North America Clinical CRO Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Clinical CRO Market Size by Country (2018-2023)
6.4.3 North America Clinical CRO Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Clinical CRO Market Size (2018-2029)
7.2 Europe Clinical CRO Market Size by Type
7.2.1 Europe Clinical CRO Market Size by Type (2018-2023)
7.2.2 Europe Clinical CRO Market Size by Type (2024-2029)
7.2.3 Europe Clinical CRO Market Share by Type (2018-2029)
7.3 Europe Clinical CRO Market Size by Application
7.3.1 Europe Clinical CRO Market Size by Application (2018-2023)
7.3.2 Europe Clinical CRO Market Size by Application (2024-2029)
7.3.3 Europe Clinical CRO Market Share by Application (2018-2029)
7.4 Europe Clinical CRO Market Size by Country
7.4.1 Europe Clinical CRO Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Clinical CRO Market Size by Country (2018-2023)
7.4.3 Europe Clinical CRO Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Clinical CRO Market Size (2018-2029)
8.2 China Clinical CRO Market Size by Type
8.2.1 China Clinical CRO Market Size by Type (2018-2023)
8.2.2 China Clinical CRO Market Size by Type (2024-2029)
8.2.3 China Clinical CRO Market Share by Type (2018-2029)
8.3 China Clinical CRO Market Size by Application
8.3.1 China Clinical CRO Market Size by Application (2018-2023)
8.3.2 China Clinical CRO Market Size by Application (2024-2029)
8.3.3 China Clinical CRO Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Clinical CRO Market Size (2018-2029)
9.2 Asia Clinical CRO Market Size by Type
9.2.1 Asia Clinical CRO Market Size by Type (2018-2023)
9.2.2 Asia Clinical CRO Market Size by Type (2024-2029)
9.2.3 Asia Clinical CRO Market Share by Type (2018-2029)
9.3 Asia Clinical CRO Market Size by Application
9.3.1 Asia Clinical CRO Market Size by Application (2018-2023)
9.3.2 Asia Clinical CRO Market Size by Application (2024-2029)
9.3.3 Asia Clinical CRO Market Share by Application (2018-2029)
9.4 Asia Clinical CRO Market Size by Region
9.4.1 Asia Clinical CRO Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Clinical CRO Market Size by Region (2018-2023)
9.4.3 Asia Clinical CRO Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Clinical CRO Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Clinical CRO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Clinical CRO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Clinical CRO Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Clinical CRO Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Clinical CRO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Clinical CRO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Clinical CRO Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Clinical CRO Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Clinical CRO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Clinical CRO Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Clinical CRO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Clinical CRO Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Clinical CRO Introduction
11.1.4 IQVIA Revenue in Clinical CRO Business (2018-2023)
11.1.5 IQVIA Recent Developments
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance Clinical CRO Introduction
11.2.4 Covance Revenue in Clinical CRO Business (2018-2023)
11.2.5 Covance Recent Developments
11.3 Syneos Health
11.3.1 Syneos Health Company Details
11.3.2 Syneos Health Business Overview
11.3.3 Syneos Health Clinical CRO Introduction
11.3.4 Syneos Health Revenue in Clinical CRO Business (2018-2023)
11.3.5 Syneos Health Recent Developments
11.4 Pharmaceutical Product Development（PPD）
11.4.1 Pharmaceutical Product Development（PPD） Company Details
11.4.2 Pharmaceutical Product Development（PPD） Business Overview
11.4.3 Pharmaceutical Product Development（PPD） Clinical CRO Introduction
11.4.4 Pharmaceutical Product Development（PPD） Revenue in Clinical CRO Business (2018-2023)
11.4.5 Pharmaceutical Product Development（PPD） Recent Developments
11.5 PAREXEL International
11.5.1 PAREXEL International Company Details
11.5.2 PAREXEL International Business Overview
11.5.3 PAREXEL International Clinical CRO Introduction
11.5.4 PAREXEL International Revenue in Clinical CRO Business (2018-2023)
11.5.5 PAREXEL International Recent Developments
11.6 MedPace
11.6.1 MedPace Company Details
11.6.2 MedPace Business Overview
11.6.3 MedPace Clinical CRO Introduction
11.6.4 MedPace Revenue in Clinical CRO Business (2018-2023)
11.6.5 MedPace Recent Developments
11.7 Clintec
11.7.1 Clintec Company Details
11.7.2 Clintec Business Overview
11.7.3 Clintec Clinical CRO Introduction
11.7.4 Clintec Revenue in Clinical CRO Business (2018-2023)
11.7.5 Clintec Recent Developments
11.8 PRA Health Sciences
11.8.1 PRA Health Sciences Company Details
11.8.2 PRA Health Sciences Business Overview
11.8.3 PRA Health Sciences Clinical CRO Introduction
11.8.4 PRA Health Sciences Revenue in Clinical CRO Business (2018-2023)
11.8.5 PRA Health Sciences Recent Developments
11.9 KCR
11.9.1 KCR Company Details
11.9.2 KCR Business Overview
11.9.3 KCR Clinical CRO Introduction
11.9.4 KCR Revenue in Clinical CRO Business (2018-2023)
11.9.5 KCR Recent Developments
11.10 ICON
11.10.1 ICON Company Details
11.10.2 ICON Business Overview
11.10.3 ICON Clinical CRO Introduction
11.10.4 ICON Revenue in Clinical CRO Business (2018-2023)
11.10.5 ICON Recent Developments
11.11 Quintiles Transnational
11.11.1 Quintiles Transnational Company Details
11.11.2 Quintiles Transnational Business Overview
11.11.3 Quintiles Transnational Clinical CRO Introduction
11.11.4 Quintiles Transnational Revenue in Clinical CRO Business (2018-2023)
11.11.5 Quintiles Transnational Recent Developments
11.12 Parexel
11.12.1 Parexel Company Details
11.12.2 Parexel Business Overview
11.12.3 Parexel Clinical CRO Introduction
11.12.4 Parexel Revenue in Clinical CRO Business (2018-2023)
11.12.5 Parexel Recent Developments
11.13 Charles River Laboratories (CRL)
11.13.1 Charles River Laboratories (CRL) Company Details
11.13.2 Charles River Laboratories (CRL) Business Overview
11.13.3 Charles River Laboratories (CRL) Clinical CRO Introduction
11.13.4 Charles River Laboratories (CRL) Revenue in Clinical CRO Business (2018-2023)
11.13.5 Charles River Laboratories (CRL) Recent Developments
11.14 Medidata Solutions
11.14.1 Medidata Solutions Company Details
11.14.2 Medidata Solutions Business Overview
11.14.3 Medidata Solutions Clinical CRO Introduction
11.14.4 Medidata Solutions Revenue in Clinical CRO Business (2018-2023)
11.14.5 Medidata Solutions Recent Developments
11.15 Pharmaron
11.15.1 Pharmaron Company Details
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Clinical CRO Introduction
11.15.4 Pharmaron Revenue in Clinical CRO Business (2018-2023)
11.15.5 Pharmaron Recent Developments
11.16 GVK Biosciences Private Limited
11.16.1 GVK Biosciences Private Limited Company Details
11.16.2 GVK Biosciences Private Limited Business Overview
11.16.3 GVK Biosciences Private Limited Clinical CRO Introduction
11.16.4 GVK Biosciences Private Limited Revenue in Clinical CRO Business (2018-2023)
11.16.5 GVK Biosciences Private Limited Recent Developments
11.17 Wuxi Pharmatech (Cayman)
11.17.1 Wuxi Pharmatech (Cayman) Company Details
11.17.2 Wuxi Pharmatech (Cayman) Business Overview
11.17.3 Wuxi Pharmatech (Cayman) Clinical CRO Introduction
11.17.4 Wuxi Pharmatech (Cayman) Revenue in Clinical CRO Business (2018-2023)
11.17.5 Wuxi Pharmatech (Cayman) Recent Developments
11.18 Hangzhou Tigermed Consulting
11.18.1 Hangzhou Tigermed Consulting Company Details
11.18.2 Hangzhou Tigermed Consulting Business Overview
11.18.3 Hangzhou Tigermed Consulting Clinical CRO Introduction
11.18.4 Hangzhou Tigermed Consulting Revenue in Clinical CRO Business (2018-2023)
11.18.5 Hangzhou Tigermed Consulting Recent Developments
11.19 Asymchem
11.19.1 Asymchem Company Details
11.19.2 Asymchem Business Overview
11.19.3 Asymchem Clinical CRO Introduction
11.19.4 Asymchem Revenue in Clinical CRO Business (2018-2023)
11.19.5 Asymchem Recent Developments
11.20 PharmaBlock Sciences
11.20.1 PharmaBlock Sciences Company Details
11.20.2 PharmaBlock Sciences Business Overview
11.20.3 PharmaBlock Sciences Clinical CRO Introduction
11.20.4 PharmaBlock Sciences Revenue in Clinical CRO Business (2018-2023)
11.20.5 PharmaBlock Sciences Recent Developments
11.21 Joinn Laboratories
11.21.1 Joinn Laboratories Company Details
11.21.2 Joinn Laboratories Business Overview
11.21.3 Joinn Laboratories Clinical CRO Introduction
11.21.4 Joinn Laboratories Revenue in Clinical CRO Business (2018-2023)
11.21.5 Joinn Laboratories Recent Developments
11.22 Crown Bioscience
11.22.1 Crown Bioscience Company Details
11.22.2 Crown Bioscience Business Overview
11.22.3 Crown Bioscience Clinical CRO Introduction
11.22.4 Crown Bioscience Revenue in Clinical CRO Business (2018-2023)
11.22.5 Crown Bioscience Recent Developments
11.23 Medicilon
11.23.1 Medicilon Company Details
11.23.2 Medicilon Business Overview
11.23.3 Medicilon Clinical CRO Introduction
11.23.4 Medicilon Revenue in Clinical CRO Business (2018-2023)
11.23.5 Medicilon Recent Developments
11.24 Jiangmen Quantum Hi-Tech Biological
11.24.1 Jiangmen Quantum Hi-Tech Biological Company Details
11.24.2 Jiangmen Quantum Hi-Tech Biological Business Overview
11.24.3 Jiangmen Quantum Hi-Tech Biological Clinical CRO Introduction
11.24.4 Jiangmen Quantum Hi-Tech Biological Revenue in Clinical CRO Business (2018-2023)
11.24.5 Jiangmen Quantum Hi-Tech Biological Recent Developments
11.25 Guangzhou Boji Medical & Biotechnological Co.,Ltd
11.25.1 Guangzhou Boji Medical & Biotechnological Co.,Ltd Company Details
11.25.2 Guangzhou Boji Medical & Biotechnological Co.,Ltd Business Overview
11.25.3 Guangzhou Boji Medical & Biotechnological Co.,Ltd Clinical CRO Introduction
11.25.4 Guangzhou Boji Medical & Biotechnological Co.,Ltd Revenue in Clinical CRO Business (2018-2023)
11.25.5 Guangzhou Boji Medical & Biotechnological Co.,Ltd Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

　

ページTOPに戻る


　

Summary

A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, clinical trials management, and pharmacovigilance.

CROs are designed to reduce costs for companies developing new medicines and drugs in niche markets. They aim to simplify entry into drug markets, and simplify development, as the need for large pharmaceutical companies to do everything ‘in house’ is now redundant. CROs also support foundations, research institutions, and universities, in addition to governmental organizations.

Market Analysis and Insights: Global Clinical CRO Market
The global Clinical CRO market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Clinical CRO is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Clinical CRO is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Clinical CRO is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Clinical CRO include IQVIA, Covance, Syneos Health, Pharmaceutical Product Development（PPD）, PAREXEL International, MedPace, Clintec, PRA Health Sciences and KCR, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes
This report presents an overview of global market for Clinical CRO market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Clinical CRO, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical CRO, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Clinical CRO revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Clinical CRO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Clinical CRO revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including IQVIA, Covance, Syneos Health, Pharmaceutical Product Development（PPD）, PAREXEL International, MedPace, Clintec, PRA Health Sciences and KCR, etc.

By Company
IQVIA
Covance
Syneos Health
Pharmaceutical Product Development（PPD）
PAREXEL International
MedPace
Clintec
PRA Health Sciences
KCR
ICON
Quintiles Transnational
Parexel
Charles River Laboratories (CRL)
Medidata Solutions
Pharmaron
GVK Biosciences Private Limited
Wuxi Pharmatech (Cayman)
Hangzhou Tigermed Consulting
Asymchem
PharmaBlock Sciences
Joinn Laboratories
Crown Bioscience
Medicilon
Jiangmen Quantum Hi-Tech Biological
Guangzhou Boji Medical & Biotechnological Co.,Ltd
Segment by Type
Discovery
CMC
Preclinical
Clinical Research
Laboratory Services
Segment by Application
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Clinical CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical CRO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical CRO revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical CRO Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Discovery
1.2.3 CMC
1.2.4 Preclinical
1.2.5 Clinical Research
1.2.6 Laboratory Services
1.3 Market by Application
1.3.1 Global Clinical CRO Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Academic Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical CRO Market Perspective (2018-2029)
2.2 Global Clinical CRO Growth Trends by Region
2.2.1 Clinical CRO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical CRO Historic Market Size by Region (2018-2023)
2.2.3 Clinical CRO Forecasted Market Size by Region (2024-2029)
2.3 Clinical CRO Market Dynamics
2.3.1 Clinical CRO Industry Trends
2.3.2 Clinical CRO Market Drivers
2.3.3 Clinical CRO Market Challenges
2.3.4 Clinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Clinical CRO by Players
3.1.1 Global Clinical CRO Revenue by Players (2018-2023)
3.1.2 Global Clinical CRO Revenue Market Share by Players (2018-2023)
3.2 Global Clinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Clinical CRO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Clinical CRO Market Concentration Ratio
3.4.1 Global Clinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical CRO Revenue in 2022
3.5 Global Key Players of Clinical CRO Head office and Area Served
3.6 Global Key Players of Clinical CRO, Product and Application
3.7 Global Key Players of Clinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical CRO Breakdown Data by Type
4.1 Global Clinical CRO Historic Market Size by Type (2018-2023)
4.2 Global Clinical CRO Forecasted Market Size by Type (2024-2029)
5 Clinical CRO Breakdown Data by Application
5.1 Global Clinical CRO Historic Market Size by Application (2018-2023)
5.2 Global Clinical CRO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical CRO Market Size (2018-2029)
6.2 North America Clinical CRO Market Size by Type
6.2.1 North America Clinical CRO Market Size by Type (2018-2023)
6.2.2 North America Clinical CRO Market Size by Type (2024-2029)
6.2.3 North America Clinical CRO Market Share by Type (2018-2029)
6.3 North America Clinical CRO Market Size by Application
6.3.1 North America Clinical CRO Market Size by Application (2018-2023)
6.3.2 North America Clinical CRO Market Size by Application (2024-2029)
6.3.3 North America Clinical CRO Market Share by Application (2018-2029)
6.4 North America Clinical CRO Market Size by Country
6.4.1 North America Clinical CRO Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Clinical CRO Market Size by Country (2018-2023)
6.4.3 North America Clinical CRO Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Clinical CRO Market Size (2018-2029)
7.2 Europe Clinical CRO Market Size by Type
7.2.1 Europe Clinical CRO Market Size by Type (2018-2023)
7.2.2 Europe Clinical CRO Market Size by Type (2024-2029)
7.2.3 Europe Clinical CRO Market Share by Type (2018-2029)
7.3 Europe Clinical CRO Market Size by Application
7.3.1 Europe Clinical CRO Market Size by Application (2018-2023)
7.3.2 Europe Clinical CRO Market Size by Application (2024-2029)
7.3.3 Europe Clinical CRO Market Share by Application (2018-2029)
7.4 Europe Clinical CRO Market Size by Country
7.4.1 Europe Clinical CRO Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Clinical CRO Market Size by Country (2018-2023)
7.4.3 Europe Clinical CRO Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Clinical CRO Market Size (2018-2029)
8.2 China Clinical CRO Market Size by Type
8.2.1 China Clinical CRO Market Size by Type (2018-2023)
8.2.2 China Clinical CRO Market Size by Type (2024-2029)
8.2.3 China Clinical CRO Market Share by Type (2018-2029)
8.3 China Clinical CRO Market Size by Application
8.3.1 China Clinical CRO Market Size by Application (2018-2023)
8.3.2 China Clinical CRO Market Size by Application (2024-2029)
8.3.3 China Clinical CRO Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Clinical CRO Market Size (2018-2029)
9.2 Asia Clinical CRO Market Size by Type
9.2.1 Asia Clinical CRO Market Size by Type (2018-2023)
9.2.2 Asia Clinical CRO Market Size by Type (2024-2029)
9.2.3 Asia Clinical CRO Market Share by Type (2018-2029)
9.3 Asia Clinical CRO Market Size by Application
9.3.1 Asia Clinical CRO Market Size by Application (2018-2023)
9.3.2 Asia Clinical CRO Market Size by Application (2024-2029)
9.3.3 Asia Clinical CRO Market Share by Application (2018-2029)
9.4 Asia Clinical CRO Market Size by Region
9.4.1 Asia Clinical CRO Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Clinical CRO Market Size by Region (2018-2023)
9.4.3 Asia Clinical CRO Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Clinical CRO Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Clinical CRO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Clinical CRO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Clinical CRO Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Clinical CRO Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Clinical CRO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Clinical CRO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Clinical CRO Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Clinical CRO Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Clinical CRO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Clinical CRO Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Clinical CRO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Clinical CRO Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Clinical CRO Introduction
11.1.4 IQVIA Revenue in Clinical CRO Business (2018-2023)
11.1.5 IQVIA Recent Developments
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance Clinical CRO Introduction
11.2.4 Covance Revenue in Clinical CRO Business (2018-2023)
11.2.5 Covance Recent Developments
11.3 Syneos Health
11.3.1 Syneos Health Company Details
11.3.2 Syneos Health Business Overview
11.3.3 Syneos Health Clinical CRO Introduction
11.3.4 Syneos Health Revenue in Clinical CRO Business (2018-2023)
11.3.5 Syneos Health Recent Developments
11.4 Pharmaceutical Product Development（PPD）
11.4.1 Pharmaceutical Product Development（PPD） Company Details
11.4.2 Pharmaceutical Product Development（PPD） Business Overview
11.4.3 Pharmaceutical Product Development（PPD） Clinical CRO Introduction
11.4.4 Pharmaceutical Product Development（PPD） Revenue in Clinical CRO Business (2018-2023)
11.4.5 Pharmaceutical Product Development（PPD） Recent Developments
11.5 PAREXEL International
11.5.1 PAREXEL International Company Details
11.5.2 PAREXEL International Business Overview
11.5.3 PAREXEL International Clinical CRO Introduction
11.5.4 PAREXEL International Revenue in Clinical CRO Business (2018-2023)
11.5.5 PAREXEL International Recent Developments
11.6 MedPace
11.6.1 MedPace Company Details
11.6.2 MedPace Business Overview
11.6.3 MedPace Clinical CRO Introduction
11.6.4 MedPace Revenue in Clinical CRO Business (2018-2023)
11.6.5 MedPace Recent Developments
11.7 Clintec
11.7.1 Clintec Company Details
11.7.2 Clintec Business Overview
11.7.3 Clintec Clinical CRO Introduction
11.7.4 Clintec Revenue in Clinical CRO Business (2018-2023)
11.7.5 Clintec Recent Developments
11.8 PRA Health Sciences
11.8.1 PRA Health Sciences Company Details
11.8.2 PRA Health Sciences Business Overview
11.8.3 PRA Health Sciences Clinical CRO Introduction
11.8.4 PRA Health Sciences Revenue in Clinical CRO Business (2018-2023)
11.8.5 PRA Health Sciences Recent Developments
11.9 KCR
11.9.1 KCR Company Details
11.9.2 KCR Business Overview
11.9.3 KCR Clinical CRO Introduction
11.9.4 KCR Revenue in Clinical CRO Business (2018-2023)
11.9.5 KCR Recent Developments
11.10 ICON
11.10.1 ICON Company Details
11.10.2 ICON Business Overview
11.10.3 ICON Clinical CRO Introduction
11.10.4 ICON Revenue in Clinical CRO Business (2018-2023)
11.10.5 ICON Recent Developments
11.11 Quintiles Transnational
11.11.1 Quintiles Transnational Company Details
11.11.2 Quintiles Transnational Business Overview
11.11.3 Quintiles Transnational Clinical CRO Introduction
11.11.4 Quintiles Transnational Revenue in Clinical CRO Business (2018-2023)
11.11.5 Quintiles Transnational Recent Developments
11.12 Parexel
11.12.1 Parexel Company Details
11.12.2 Parexel Business Overview
11.12.3 Parexel Clinical CRO Introduction
11.12.4 Parexel Revenue in Clinical CRO Business (2018-2023)
11.12.5 Parexel Recent Developments
11.13 Charles River Laboratories (CRL)
11.13.1 Charles River Laboratories (CRL) Company Details
11.13.2 Charles River Laboratories (CRL) Business Overview
11.13.3 Charles River Laboratories (CRL) Clinical CRO Introduction
11.13.4 Charles River Laboratories (CRL) Revenue in Clinical CRO Business (2018-2023)
11.13.5 Charles River Laboratories (CRL) Recent Developments
11.14 Medidata Solutions
11.14.1 Medidata Solutions Company Details
11.14.2 Medidata Solutions Business Overview
11.14.3 Medidata Solutions Clinical CRO Introduction
11.14.4 Medidata Solutions Revenue in Clinical CRO Business (2018-2023)
11.14.5 Medidata Solutions Recent Developments
11.15 Pharmaron
11.15.1 Pharmaron Company Details
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Clinical CRO Introduction
11.15.4 Pharmaron Revenue in Clinical CRO Business (2018-2023)
11.15.5 Pharmaron Recent Developments
11.16 GVK Biosciences Private Limited
11.16.1 GVK Biosciences Private Limited Company Details
11.16.2 GVK Biosciences Private Limited Business Overview
11.16.3 GVK Biosciences Private Limited Clinical CRO Introduction
11.16.4 GVK Biosciences Private Limited Revenue in Clinical CRO Business (2018-2023)
11.16.5 GVK Biosciences Private Limited Recent Developments
11.17 Wuxi Pharmatech (Cayman)
11.17.1 Wuxi Pharmatech (Cayman) Company Details
11.17.2 Wuxi Pharmatech (Cayman) Business Overview
11.17.3 Wuxi Pharmatech (Cayman) Clinical CRO Introduction
11.17.4 Wuxi Pharmatech (Cayman) Revenue in Clinical CRO Business (2018-2023)
11.17.5 Wuxi Pharmatech (Cayman) Recent Developments
11.18 Hangzhou Tigermed Consulting
11.18.1 Hangzhou Tigermed Consulting Company Details
11.18.2 Hangzhou Tigermed Consulting Business Overview
11.18.3 Hangzhou Tigermed Consulting Clinical CRO Introduction
11.18.4 Hangzhou Tigermed Consulting Revenue in Clinical CRO Business (2018-2023)
11.18.5 Hangzhou Tigermed Consulting Recent Developments
11.19 Asymchem
11.19.1 Asymchem Company Details
11.19.2 Asymchem Business Overview
11.19.3 Asymchem Clinical CRO Introduction
11.19.4 Asymchem Revenue in Clinical CRO Business (2018-2023)
11.19.5 Asymchem Recent Developments
11.20 PharmaBlock Sciences
11.20.1 PharmaBlock Sciences Company Details
11.20.2 PharmaBlock Sciences Business Overview
11.20.3 PharmaBlock Sciences Clinical CRO Introduction
11.20.4 PharmaBlock Sciences Revenue in Clinical CRO Business (2018-2023)
11.20.5 PharmaBlock Sciences Recent Developments
11.21 Joinn Laboratories
11.21.1 Joinn Laboratories Company Details
11.21.2 Joinn Laboratories Business Overview
11.21.3 Joinn Laboratories Clinical CRO Introduction
11.21.4 Joinn Laboratories Revenue in Clinical CRO Business (2018-2023)
11.21.5 Joinn Laboratories Recent Developments
11.22 Crown Bioscience
11.22.1 Crown Bioscience Company Details
11.22.2 Crown Bioscience Business Overview
11.22.3 Crown Bioscience Clinical CRO Introduction
11.22.4 Crown Bioscience Revenue in Clinical CRO Business (2018-2023)
11.22.5 Crown Bioscience Recent Developments
11.23 Medicilon
11.23.1 Medicilon Company Details
11.23.2 Medicilon Business Overview
11.23.3 Medicilon Clinical CRO Introduction
11.23.4 Medicilon Revenue in Clinical CRO Business (2018-2023)
11.23.5 Medicilon Recent Developments
11.24 Jiangmen Quantum Hi-Tech Biological
11.24.1 Jiangmen Quantum Hi-Tech Biological Company Details
11.24.2 Jiangmen Quantum Hi-Tech Biological Business Overview
11.24.3 Jiangmen Quantum Hi-Tech Biological Clinical CRO Introduction
11.24.4 Jiangmen Quantum Hi-Tech Biological Revenue in Clinical CRO Business (2018-2023)
11.24.5 Jiangmen Quantum Hi-Tech Biological Recent Developments
11.25 Guangzhou Boji Medical & Biotechnological Co.,Ltd
11.25.1 Guangzhou Boji Medical & Biotechnological Co.,Ltd Company Details
11.25.2 Guangzhou Boji Medical & Biotechnological Co.,Ltd Business Overview
11.25.3 Guangzhou Boji Medical & Biotechnological Co.,Ltd Clinical CRO Introduction
11.25.4 Guangzhou Boji Medical & Biotechnological Co.,Ltd Revenue in Clinical CRO Business (2018-2023)
11.25.5 Guangzhou Boji Medical & Biotechnological Co.,Ltd Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/20　10:26

143.76 円

160.81 円

193.57 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.